The shareholders of Dacia Plant relied on the legal advice of Wolf Theiss regarding the sale of a majority stake to Belgian-based Ceres Pharma, a pharmaceutical company active in women and family healthcare. Dacia Plant is a wholly Romanian-owned company and one of the pioneers as well as a top three player in the development, production and distribution of qualitative and innovative natural food supplements in Romania.
Călin Ioan Ianţa and Radu Ionescu-Heroiu, the shareholders of Dacia Plant, one of the best-known dietary supplements brands in Romania, successfully finalised the negotiations and signed the agreement for the sale of the majority stake in Dacia Plant S.R.L.. Ceres Pharma will strengthen its position in the Romanian market through this acquisition, which is of high strategic importance since it expands their product portfolio in Europe.
Wolf Theiss’ Corporate / M&A team in Bucharest, led by Partner Ileana Glodeanu, acted as legal advisor to the shareholders of Dacia Plant in all stages of the transaction.
Together with Partner Ileana Glodeanu, the Corporate / M&A lawyers who assisted with the deal were Senior Associates Luciana Tache and Mihai Coadă, as well as Associates Roxana Balica and Iulia Cumpăratu.
“We would like to thank Ileana, Luciana and Mihai for their continuous help from the beginning of the sale process until the successful finalisation of the negotiations and execution of the documents. The negotiation process proved to be more complicated than initially envisaged by us, but we are grateful to Ileana and her team for helping us to resolve the impediments and finding solutions to complicated and challenging matters“, declared Călin Ioan Ianţa.
Radu Ionescu-Heroiu added, “We really appreciated the business and pro-active approach of Ileana, always able to find solutions and guide us through the process. Her negotiation skills and dedication are outstanding, she is a force “.
“With the demand for natural products increasing everywhere, we are thankful for the trust Dacia Plant placed in us to advise them in this strategic transaction. Our Corporate M&A team has been very active in assisting with some of the largest transactions in the Romanian market, both in the pharmaceutical and healthcare sectors and particularly those transactions involving Romanian entrepreneurs. It was a pleasure for us to work together with the two shareholders, Călin and Radu, to make the sale process a success. I am very proud of our Corporate / M&A team as we managed to complete one more deal in this very interesting sector”, stated Ileana Glodeanu, Partner and Head of the Corporate / M&A practice at the Wolf Theiss Bucharest office.